The Neurosurgery Signal — Signal, Not Noise

Rapid review note

Journal Club is a rapid, AI-assisted appraisal layer. It highlights study design, effect estimates, and practice relevance, but it is still a briefing, not a replacement for the paper.

For education only. Not medical advice.

Paper snapshot

Rapid study overview

Open paper

DOI

10.1056/NEJMoa1207363

PMID

23234472

PICO

Population

324 patients ≥13 years with severe traumatic brain injury treated in ICUs in Bolivia or Ecuador

Intervention

Guidelines-based management with intraparenchymal intracranial pressure monitoring (pressure-monitoring group)

Comparator

Protocol based on imaging and clinical examination (imaging-clinical examination group)

Outcomes

Composite of survival time, impaired consciousness, functional status at 3 and 6 months, neuropsychological status at 6 months; 6-month mortality; ICU length of stay; days of brain-specific treatments

Design

Type

Multicenter randomized controlled trial

Randomized

Yes

Multicenter

Yes

Blinded

Outcome assessors blinded for neuropsychological status

Follow-up

6 months

Primary endpoint

Composite percentile score across 21 measures of functional and cognitive status

Secondary endpoints

6-month mortality
Median ICU length of stay
Days of brain-specific treatments in ICU

Practice impact

What this means

This RCT in South America found no difference in 6-month functional/cognitive outcomes between ICP monitoring and imaging/clinical exam-based management for severe TBI. Mortality and ICU length of stay were similar. The study challenges the universal necessity of ICP monitoring, suggesting protocolized care without monitoring may be equally effective in certain settings.

Bottom line

ICP monitoring did not improve functional/cognitive outcomes vs imaging/clinical exam-based care in severe TBI

Strength of evidence

moderate

Recommendation

consider change

Why it matters

Randomized trial showing no benefit in primary composite outcome
Similar mortality and ICU stay between groups
Higher brain-specific treatment days in non-monitoring group suggests alternative management can be effective

What would change my mind

Replication in high-resource settings with different patient populations
Long-term follow-up showing delayed divergence in outcomes
Subgroup analysis identifying patients who benefit from monitoring

Critical appraisal

How strong is the paper?

Methods critique

Risk of bias

Low risk: randomization, multicenter, blinded outcome assessment for neuropsychological status

Confounding

Minimal: randomized design, baseline characteristics balanced

Missing data

Not explicitly detailed in excerpt; likely handled per protocol

Multiplicity

Primary outcome composite; no multiplicity adjustment mentioned for secondary outcomes

Notes

Conducted in Bolivia/Ecuador; may limit generalizability to high-resource settings

Stats check

NNT

N/A

Effect sizes

Primary composite score: 56 vs 53 (P=0.49)
6-month mortality: 39% vs 41% (P=0.60)
Days of brain-specific treatments: 3.4 vs 4.8 (P=0.002)

Absolute effects

324 patients randomized
Median ICU stay: 12 days vs 9 days (P=0.25)

Concerns

Composite primary outcome may dilute individual component effects
No adjustment for multiple secondary comparisons

External validity

Who it applies to

Adolescents and adults with severe TBI in ICU settings, particularly in resource-limited environments

Who it does not

Pediatric patients <13 years, mild/moderate TBI, high-income settings with different care protocols

Generalizability notes

Single study in South America; may not reflect practices in North America/Europe
Protocolized care may differ from real-world variability

Evidence trace

Source trace and metadata

Citations (3)

claim_id

methods_critique.risk_of_bias

locator

p. 2471 Methods

quote

multicenter, controlled trial... randomly assigned... neuropsychological status was assessed by an examiner who was unaware of protocol assignment

claim_id

stats_check.effect_sizes

locator

p. 2471 Results

quote

score, 56 in the pressure-monitoring group vs. 53 in the imaging–clinical examination group; P = 0.49

claim_id

practice_impact.bottom_line

locator

p. 2471 Results

quote

There was no significant between-group difference in the primary outcome

Metadata

Generated at

2026-03-06T13:41:29.251Z

Version

top 100 cited in past 20 years